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African-American women who use crack are vulnerable to HIV because of the complex social circumstances in which they live.
Drug-abuse treatment for these women during pregnancy may provide time for changing risk behaviors. This paper examines
the initial 6-month feasibility of a women-focused HIV intervention, the Women’s CoOp, adapted for pregnant women, relative
to treatment-as-usual among 59 pregnant African-American women enrolled in drug-abuse treatment. At treatment entry, the
women were largely homeless, unemployed, practicing unsafe sex, and involved in violence. Results indicated marked reductions
in homelessness, use of cocaine and illegal drugs, involvement in physical violence, and an increase in knowledge of HIV from
baseline to 6-month followup for both conditions. Findings suggest that the Women’s CoOp intervention could be successfully
adapted to treat this hard-to-reach population. Future studies should examine the eﬃcacy of the pregnancy-adapted Women’s
CoOp for women not enrolled in drug-abuse treatment.
1.Introduction
The risk of contracting HIV is one of the most devastating
health threats African-American women who use crack
cocaine face. HIV prevalence rates among African-American
women range from a low rate of 1.7% among noninjecting
drug users who do not trade sex to a high rate of 54% among
homeless African-American women, many of whom trade
sexfordrugsand survival items[1–5].Crackcocaineusealso
has been repeatedly associated with increased sexual activity;
if the sex is unprotected, unplanned pregnancies and HIV
can result [6, 7].
African-American women who use crack are vulnerable
to HIV because of the complex social circumstances in
which they live. These social circumstances may produce
situations where these women engage in multiple high-risk
HIV behaviors [8]. Furthermore, the combination of crack,
alcohol use, and sexual-risk behaviors (e.g., trading sex for
drugs or survival items, inconsistent condom use, multiple
partners) place African-American women at greater risk for
HIV infection than other drug-using groups [9].
Many of these crack-using African-American women
lack self-suﬃciency, rely on public assistance for long
durations, are often unstably housed, experience repeated
episodes of homelessness, have no or scanty employment
records, lack education and job skills, and live in poverty [9–
15]. The lives of substance-using African-American women
also are often characterized by inﬂicting or being a victim
of violence, crime, childhood and current sexual, physical,
and emotional victimization, as well as symptoms of anxiety,
depression, and posttraumatic stress disorder [9, 16–18].
Many of these African-American women’s struggles
against social, cultural, and economic subordination include
survival strategies that have the burden of drug use, sexual
risk, HIV risk, homelessness, and violence [19]. In the
context of this inequality, many impoverished African-
American women also face unplanned pregnancies [20]a n d
poorpregnancyoutcomes[21].Inallbuttherarestcases,licit2 International Journal of Pediatrics
and illicit substance-use starts well before pregnancy [22].
Drug use during pregnancy is associated with a multitude of
adverse maternal, fetal, and neonatal outcomes, which occur
in the context of poverty and psychosocial and environmen-
tal concerns. Substance-using pregnant African-American
women tend to have completed approximately 11 years of
education, be unmarried, have a history of substance-use in
theirfamilies, havea history of physicaland sexual victimiza-
tion, have signiﬁcant health and/or mental health problems
(e.g., depression and/or anxiety), have current problems
with criminal justice, have current and/or past involvement
with Child Protective Services, lack stable housing, and
be unemployed with poor vocational training [23–26]. As
such, pregnant African-American women with substance
use disorders are a very vulnerable population with meager
support networks and few, if any, resources [27]. Yet they
are often the targets of prejudicial and judgmental treatment
by health care providers and coercive policies implemented
by child welfare systems, juvenile/family courts, and the
criminal justice system [28, 29].
These barriers frequently deter African-American wom-
en with substance-use disorders from seeking concurrent
prenatal care and substance use disorder treatment. The
social, cultural, and economic subordination that African-
American women face set the stage for a lack of prenatal
care and an array of medical and obstetrical complications,
reducing the chances of a healthy pregnancy outcome
regardless of the eﬀects of the drug(s) they are abusing.
These adverse eﬀects can be even further compounded if the
pregnant woman has HIV. Thus, African-American women
who are using crack cocaine are in critical need of an
effective HIV risk-reduction intervention that acknowledges
the multiple adverse inﬂuences in their lives, addresses
their speciﬁc barriers to success, and empowers them to
make positive choices in their lives for themselves and their
children.
The most eﬀective HIV risk-reduction interventions
for women are based on social psychological theory and
are women-focused, culturally sensitive, and incorporate
women-only sessions led by peers [30]. The Women’s CoOp
is an intervention that has resulted in HIV-risk behavior
reduction in African-American women, and it has shown
consistent reductions in homelessness and increases in
employment as well as in condom use [30]. Given these
improvementsin risk behavioramong nonpregnant African-
American women, it was important to see if this intervention
could be adapted for pregnant African-American women
who, once pregnant, are at increased vulnerability for the
consequences of HIV risk behavior, violence, homelessness,
and unemployment [31].
1.1. Purpose of the Present Study. The purpose of the study
is twofold. First, we will describe the multifaceted HIV
risk behaviors and the psychosocial service needs of a
sample of African-American pregnant women enrolled in
drug-abuse treatment. Second, we will examine the initial
feasibility of an adapted women-focused HIV intervention,
Women’s CoOp for Pregnant African-American Women,
relative to treatment-as-usual for drug-abusing, pregnant
African-American women in treatment. The intervention
and the process to adapt it are described elsewhere [31]. This
paper summarizes the results of the 6-month outcomes, the
ﬁnal time point of evaluation.
2.Methods
2.1. Study Design. A small-scale randomized clinical trial
with pregnant African-American women in drug-abuse
treatment was begun in May 2007 to measure the feasibility
of the Women’s CoOp for Pregnant African-American
Women intervention relative to treatment-as-usual in mul-
tiple areas (e.g., substance abuse, HIV risk, homelessness,
employment, intimate partner violence, and birth outcomes.
This study was approved by the IRB of RTI International.
Because the procedures of this study have been reported
elsewhere [31]; a full summary ofprocedures is not provided
here.
2.2. Outreach. Participants were recruited through targeted
outreach, regional drug treatment centers, radio advertise-
ments, and referrals from health department oﬃcials in
North Carolina. Any out-of-treatment women were ﬁrst
referred to drug-abuse treatment. After drug-abuse treat-
ment entry, these women could be enrolled in the study.
2.3. Eligibility Criteria. Eligibility criteria included being
female, at least 18 years of age, self identiﬁed as Black/Afri-
can-American, at least 14 weeks and not more than 32 weeks
pregnant (pregnancy determined by urine testing and self
reported gestational age based upon last menstrual period),
and currently enrolled in a drug-abuse treatment program.
Participants also needed to self-report use of an illicit drug
within the past year. Additional eligibility criteria included
being willing and with the cognitive capacity to provide
written informed consent and being willing to provide
veriﬁable locator information for followup assessments [31].
2.4. Recruitment. Women were recruited between May 2007
and February 2009. In total, 96 women were screened for
the study, of whom 37 were found to be ineligible, including
treatment refusals (n = 23), lack of self-reported use of any
illicit drug in the past year (n = 21), outside the gestation
window (n = 12), and not being pregnant (n = 6). Thus,
59 women from 11 diﬀerent drug-abuse treatment programs
were randomized into one of two study conditions, either
the Women’s CoOp for Pregnant African-American Women
(n = 30) or treatment-as-usual (n = 29) after their baseline
assessment [31].
2.5. Data Collection. At both baseline and followup assess-
ments, participants were asked to complete a urine
drug screen for methamphetamine, amphetamine, cocaine,
heroin, marijuana, and ecstasy and an audio computer-
assisted self-interview (ACASI) that included demographic
(baseline only) and health-related questions regarding sub-
stance use, sexual-risk behaviors, experiences with violence,International Journal of Pediatrics 3
and prenatal care [31]. Followup interviews were then
collected at 3 months (data not analyzed or shown due to
amount of missing data) and 6 months following baseline
assessment, at which time 85% of the sample was assessed.
2.6. Intervention Conditions
2.6.1. The Women’s CoOp for Pregnant African-American
Women. The Women’s CoOp for Pregnant African-
American Women in drug-abuse treatment was developed
from the original Women’s CoOp that focuses on preventing
HIV through drug use and sexual-risk reduction, improving
relationships with men and social support, and receiving
HIV testing [30]. Behavioral skills training (e.g., male
and female condom demonstration and practice), roleplay
to improve negotiation and communication skills, and
personalized risk-reduction plans are key elements of the
intervention [30]. Women’s CoOp for Pregnant African-
AmericanWomenretainedthecoreelementsoftheWomen’s
CoOp, and also included material on the risks of using drugs
while pregnant, parenting, violence and victimization, and
use of antiretroviral therapy (ART). The program also
used short video vignettes of African-American women to
emphasize key points [31].
2.6.2.Treatment-As-Usual Control Group. The control group
received no intervention beyond what they received as a part
of the treatment program in which they were enrolled.
2.7. Measures
2.7.1. The Revised Risk Behavior Assessment (RRBA). The
RRBA has 10 sections, which contain questions about
demographics and social characteristics; health knowledge;
a l c o h o lu s e ;d r u gu s e ;d r u gi n j e c t i n g ;s e x u a lp r a c t i c e s ;p o w e r
and empowerment; conﬂict and victimization (stigma and
vulnerability); physical and mental health and HIV.
Although the RRBA has excellent psychometric prop-
erties for African-American women [9], an adaptation was
necessary to measure particular concerns related to pregnant
women. Based on a review of the literature and consultation
with experts, several new questions were added. Speciﬁcally,
experiences with personal violence were assessed by asking
the participant how many times in the past 90 days she
behaved in a violent manner toward others, including
insulting or swearing at someone, beating up someone, and
using a knife or gun on someone (Cronbach’s Alpha = 0.91).
These items were condensed into an indication of violent
behavior in the past 90 days. Moreover, a 22-item scale
adapted from the RRBA assessed participants’ knowledge
about HIV and STD transmission, drug and alcohol use, and
substance-use inﬂuence on fetal development (Cronbach’s
Alpha = 0.71). These items were combined into a total HIV
and drug risk knowledge score with a range of scores from 0
to 22.
An ACASIversion was administered to insure privacy for
respondents, given the inclusion of more intimate violence
measures.
2.7.2. Urine Drug Testing. Urine drug testing for metham-
phetamine, amphetamine, cocaine, heroin, marijuana, and
ecstasy was conducted at baseline and followup using a rapid
6-panel urine dip test.
3.Analysis
Analytic methods began with descriptive statistics on demo-
graphic variables of interest (e.g., age, employment status,
marital status, homeless status), followed by inferential
analyses on the outcome variables of interest using t-tests on
continuousdatatocomparetheWomen’sCoOpforPregnant
African-American Women and treatment-as-usual condi-
tions within time and chi-squared analyses for dichotomous
and ordinal data. Subscale items combined into an additive
or averaged scale score were assessed through Cronbach’s
Alpha reliability to check internal consistency. Only those
scales with an acceptable statistic (α = 0.70 or greater)
were included in the analyses. In addition to the descriptive
and reliability analyses, change-over-time assessments were
conducted for the substance-use, sexual-risk, and violence
outcomes of interest using the paired t-test for continuous
data, the McNemar test for dichotomous data, and the
Wilcoxonsigned-ranks testforordinaldata.Allanalyseswere
conducted using the SAS 9.2 statistical software. Because
both the Women’s CoOp for Pregnant African-American
Women and treatment-as-usual addressed the importance of
substance-use reduction, an overall reduction in drug and
alcohol use over time in both intervention conditions was
expected.
4.Results
4.1. Participant Demographics and Characteristics. Table 1
shows that on average, randomized participants were in
their late twenties, and a majority had less than a high
school education, had never married, and reported that this
pregnancy was unplanned. The average gestational age at
study entry was 24 weeks (SD = 7.0). Women reported
being an average of 10 weeks pregnant (SD = 7.0) at the
time of pregnancy awareness, 88% reported having received
at least some prenatal care, and 97% reported planning to
keep the baby after delivery (some data are not shown in
Table 1). Of note, the Women’s CoOp for Pregnant African-
American Women and treatment-as-usual conditions did
not signiﬁcantly diﬀer at baseline on any of the measures
found in Table 1 or reported in the text.
An examination of baseline characteristics of women
who completed 6-month followup surveys indicates the
severe social circumstances that the sample experienced
when they entered this study (Table 2). More than 40%
were homeless, and more than 75% were unemployed;
18% reported that they had an alcohol problem, and 58%
reported that they had a drug problem. On a positive note,
the participants had good knowledge of the risks of HIV and
the eﬀects of prenatal exposure to drugs of abuse, correctly
answering, on average, 18 of the 22 questions. However, in
the past 90 days, 33% of women who had sex indicated4 International Journal of Pediatrics
Table 1: Baseline demographicand background characteristics for the total sample and the Women’s CoOp for Pregnant African-American
Women and treatment-as-usual conditions.
Total sample
(N = 59)
Women’s CoOp
(n = 30)
Treatment-as-
usual
(n = 29)
P
Demographic Characteristics
M (SD)
Maternal age in years 28.7 (6.6) 28.2 (5.7) 29.2 (7.5) .76
f (%)
Race: Black/African American 59 (100%) 30 (100%) 29 (100%) —
Education
Completed high school 21 (36%) 10 (33%) 11 (38%) .79
Relationship status
Never married 48 (81%) 23 (77%) 25 (86%) .51
Pregnancy
Unplanned 53 (90%) 27 (90%) 26 (90%) 1.00
Had you gone for prenatal care for this pregnancy? 52 (88%) 28 (93%) 24 (83%) .25
Used any drugs since you found out pregnant? 41 (70%) 22 (73%) 19 (66%) .58
Interpersonal violence
Ever been physically abused:
Never 44% 40% 48% .60
More than 12 months ago 31% 33% 28% .78
One year ago or less 25% 27% 10% .18
Ever been sexually abused:
Never 58% 50% 66% .29
More than 12 months ago 31% 37% 24% .40
One year ago or less 12% 13% 10% 1.00
The test statistic for maternal age was the independent-samples t-test. The remaining variables were tested with the χ2 goodness-of-ﬁt test, with df = 1.
Probability values for the χ2 tests are exact. Percentages are within the respective group.
that they had never used a condom, and 62% indicated
that they had been in violent situations in which they were
violent toward someone else. Nonetheless, in both cases,
more than 75% of the sample reported that they want to
stop/reduce using drugs for themselves, and 80% wanted
to stop/reduce drug use to have a healthy baby, indicating
substantial motivation on the part of the participants as
they participated in drug-abuse treatment. Motivation for
reducing or stopping drug use also was found in over half
of the women in the sample, who were fearful that Child
ProtectiveServiceswouldtaketheirchild away iftheydid not
change their drug use behavior.
Finally, it should be noted that the Women’s CoOp for
Pregnant African-American Women and treatment-as-usual
conditions did not signiﬁcantly diﬀer at baseline on any of
the outcome measures found in Table 2 (all Ps >. 17).
4.2. Intervention Evaluation. There were marked reductions
in homelessness in both groups at 6-month followup (see
Table 2), suggesting that the women were ﬁnding stable
housing. Use of cocaine and illegal drugs dropped markedly,
as did threats of physical violence toward others. Further, on
average,the participant’s knowledge about HIVand the risks
of prenatal drug exposure increased, showing improvement
from baseline assessment to 6-month followup. There were
no signiﬁcant diﬀerences between the Women’s CoOp con-
dition and the treatment-as-usual conditionin the outcomes
presented in Table 2. Although a stronger design would
have included a no-treatment control condition to fully
assess treatment eﬃcacy, the present study focused primarily
on feasibility of the Women’s Coop for pregnant African-
American women.
In contrast to the prior examination of the Women’s
CoOp in non-pregnant African-American women [30], this
sample of pregnant women showed no improvement in
unemployment.
However, it is important to note that each of the
signiﬁcant changes from baseline to followup for the entire
sample was signiﬁcant among just women included in the
Women’s CoOp condition.
4.3. Birth Outcomes. Two study participants had miscar-
riages during the study, one Women’s CoOp for Pregnant
African-American Women participant and one treatment-
as-usual participant, at the gestational ages of 28 and
30 weeks, respectively. The Women’s CoOp for Pregnant
African-American Women and control conditions both
resulted in, on average, term births, 38.2 weeks (SD = 1.9)International Journal of Pediatrics 5
Table 2: Outcomes for the six-month reduced sample.
Diﬀerences over time
Total sample
Baseline 6-month P
Currently homeless 42% 6% <.001
Currently unemployed 78% 70% .41
Past 90 days, used
Cocaine, any form 56% 36% .03
Use of one or more of illegal drugs (methamphetamine, amphetamine, cocaine,
heroin, marijuana, and/or ecstasy)
82% 52% .001
Reason quit/cut back drugs
Want to get clean for myself 78% 84% .18
Wanted to have healthy baby 80% 76% .16
Child Protective Services would take baby away 56% 50% .44
What helped you stay clean and sober the most
Treatment 36%
Staying away from people (you) used to drink, get high with OR places (you) used
to drink, get high OR old neighborhood
38%
In the past 90 days, one or more times
Meeting with specialist about relationship with spouse or family member 30% 18% .16
Meeting with specialist on parenting 46% 38% .43
Meeting with specialist regaining contact 32% 6% .002
Meeting with specialist on getting along with children 44% 28% .1
Meeting focused on regaining contact with children 34% 12% .01
Any meeting or session 56% 76% .03
Current alcohol and drug problem
Have alcohol problem at this time 18% 28% .23
Have drug problem at this time 58% 62% .67
Sexual behavior and HIV and prenatal drug use knowledge
How many days in the past 90 did you have any sex? (Mean (SD)) 18 (25) 11 (21) .13
HIV and prenatal drug risk knowledge: Total score (Mean (SD)) 18 (3) 21 (2) <.001
Condom use in past 90 days N = 21 .51
Never 33% 38%
Almost never 10% 14%
Any use 57% 48%
Can insist on condom use with main sex partner in past 90 days 50% (N = 18) 61% .53
Past 90 days threatened any violence
Threatened any violence 62% 34% .003
N = 50 due to missing data at 6-month followup. The tests of the diﬀerences over time are based on the McNemar test for matched data, with the exception
of the tests for condom use, which are based on the Wilcoxon signed-rank test, and the number of days in the past 90 days on which the respondent had any
sex and the HIV knowledge: total score, which are based on the paired t-test.
and 37.2 weeks (SD = 5.8), respectively. The mean birth
weight, length, and head circumference also were within
normal limits for gestational age in both the Women’s CoOp
for Pregnant African-American Women and treatment-as-
usual conditions.
5.Discussion
There are several notable ﬁndings from this initial exami-
nation of the feasibility of this evidence-based intervention
modiﬁed for pregnant women. First, this study conﬁrms
and emphasizes the ability of outpatient drug-abuse treat-
ment to reduce cocaine and other illegal drug use among
pregnant women in an extent similar to non-pregnant
patients [32]. These results, coupled with promising birth
outcomes, underscore the ability of pregnant women to
make meaningful changes in their drug use behavior and
serves as evidence that intervention tailored speciﬁcally to
the needs of pregnant women can be successful. Second,
this study suggests that, as with the original Women’s CoOp,
theWomen’sCoOpwithpregnant African-American women6 International Journal of Pediatrics
showed reductions in homelessness for its participants.
While both the Women’s CoOp for Pregnant African-
American Women and the treatment-as-usual conditions
showed marked improvements in helping women to secure
housing only the Women’s CoOp for Pregnant African-
American Women reduced it to 0%. This reduction in
homelessness is similar to that of the Women’s CoOp for
non-pregnant African-American women [30]. Third, the
data from this initial feasibility study of the adaption of
the Women’s CoOp for pregnant women suggests that this
intervention could be successful in teaching women the
needed skills to avoid violent situations and/or not use
violence against others in situations. Fourth, this study
provides valuable information regarding the extent to which
these women had unplanned pregnancies that brought them
into treatment. The fact that 9 out of 10 women reported an
unplanned pregnancy speaks to the dire need for education
regarding family planning options, access to these options,
and the skills and support to implement their chosen family
planningmethod.Datafromthisstudyalsodemonstratethat
pregnant African-American women in drug-abuse treatment
continue to have low rates of condom use and are unable
to insist on condom use with partners all the time. These
results support the need for drug-abuse treatment programs
to infuse and integrate HIV sexual-risk reduction messages,
education, and skills practice into their programs. Finally,
our results, although not deﬁnitive, certainly speak to the
importance of future research to more fully examine the
eﬃcacy of Women’s CoOp with pregnant African-American
women.
6.StudyLimitations
The present study is not without its limitations. First, it is
an initial feasibility study undertaken to examine the poten-
tial utility of the Women’s CoOp with pregnant African-
American women. Therefore, the impact of the intervention
would not be expected to be maximal relative to the success
ofotherWomen’sCoOpinterventions.Second,because23of
the 96 (24%) women screened for the study were ineligible
due to refusal of drug-abuse treatment, the generalizability
ofthe results to the larger pregnant drug-abusing population
maybelimited;however,thisresultspeakstothefear, stigma,
and concern women have with drug-abuse treatment and
the need for future studies to examine ways of changing
treatment to be more attractive to these participants. Third,
the sample was quite diverse in its use of licit and illicit
substances. This diversity may have adversely impacted the
eﬃcacy of this adaptation of the Women’s CoOp inter-
vention, since the original version of the Women’s CoOp
targeted crack-abusing African-American women. Fourth,
in contrast to other examinations of the Women’s CoOp,
this study tested the intervention in the context of intensive
outpatient drug-abuse treatment. This intense service may
havecompromisedtheabilitytoseeimprovementsspeciﬁcto
the Women’s CoOp. Fifth, because of the small sample size,
the study may have insuﬃcient power to detect signiﬁcant
changes in some outcomes. Finally, despite that RRBA was
revised for the present study, further research establishing
its reliability and validity in pregnant African-American
women is certainly needed. Nonetheless, results from the
current study suggest that future research should examine
the Women’s CoOp as a potentially eﬃcacious intervention
for an underserved population seriously in need of such an
intervention.
7.Conclusions
These results demonstrate not only the success of drug-
abusetreatmenttohelpimprovetheriskbehaviorsandsocial
circumstances of pregnant women but also the potential
feasibility of the Women’s CoOp to eliminate homelessness.
This pregnancy-speciﬁc adaption of the Women’s CoOp
argues for the extension of the reach of this interven-
tion by also suggesting the possibility of reduced violence
involvement for its participants. Moreover, these results
demonstrate the myriad of stressors these women face in
their daily lives and how these issues can compromise
treatment seeking and engagement. Finally, these results also
support the need for ongoing integration of family planning
andHIVsexual-risk reductionintodrug-abusetreatmentfor
pregnant African-American women.
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